<DOC>
	<DOCNO>NCT02169401</DOCNO>
	<brief_summary>08-SMI-2012 post market , observational , questionnaire base study assess effectiveness commercially available Axium neurostimulator management intractable , chronic pain .</brief_summary>
	<brief_title>A Multi-centre Observational Study Axium Neurostimulator Treatment Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>1 . Subject least 18 year old 2 . Subject able willing comply followup schedule protocol 3 . Chronic , intractable pain least 6 month 4 . Failed conservative treatment chronic pain include limited pharmacological therapy , physical therapy interventional pain procedure chronic pain 5 . Average baseline pain rating 60 mm Visual Analog Scale primary region pain 6 . In opinion Investigator , subject psychologically appropriate implantation active implantable medical device 7 . Subject able provide write informed consent 1 . Female subject childbearing potential pregnant/nursing , plan become pregnant unwilling use approve birth control 2 . Escalating change pain condition within past month evidence investigator examination 3 . Subject corticosteroid therapy intend site stimulation within past 30 day 4 . Subject radiofrequency treatment intend target DRG within past 3 month 5 . Subject currently active implantable device include implantable cardioverter defibrillator , pacemaker , spinal cord stimulator intrathecal drug pump 6 . Subject unable operate device 7 . Subjects currently active infection 8 . Subject , opinion Investigator , medical comorbidity contraindicates placement active medical device 9 . Subject participate another clinical trial within 30 day 10 . Subject coagulation disorder use anticoagulant , opinion investigator , preclude participation 11 . Subject diagnose cancer past 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>